(Q34808657)

4 August 2017

1 reference

title

B cells and multiple sclerosis (English)

1 reference

4 August 2017

0 references

Francesco Lolli

1 reference

ORCID Public Data File 2021

4 August 2017

Barbara Serafini

1 reference

author name string

Diego Franciotta

series ordinal

1 reference

4 August 2017

Marco Salvetti

series ordinal

1 reference

4 August 2017

Francesca Aloisi

series ordinal

1 reference

4 August 2017

language of work or name

1 reference

1 September 2008

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

4 August 2017

page(s)

852-858

1 reference

B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

The B cell response in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Lymphoid neogenesis in chronic inflammatory diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Blood-brain barrier damage in acute multiple sclerosis plaques. An immunocytological study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Homogeneity of active demyelinating lesions in established multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Elevated intrathecal antibodies against the medium neurofilament subunit in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Neurofascin as a novel target for autoantibody-mediated axonal injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Infectious causes of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Environmental risk factors for multiple sclerosis. Part I: The role of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Epstein-barr virus: environmental trigger of multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Patterns of oligodendroglia pathology in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

CXCL13, CCL21, and CXCL12 Expression in Salivary Glands of Patients with Sjogren's Syndrome and MALT Lymphoma: Association with Reactive and Malignant Areas of Lymphoid Organization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Lymphoid chemokines in chronic neuroinflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Epstein-Barr virus: exploiting the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

An attempt to investigate the presence of Epstein Barr virus in multiple sclerosis and normal control brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Epstein-Barr virus and disease activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

A functional and structural basis for TCR cross-reactivity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

VH4 gene segments dominate the intrathecal humoral immune response in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

A study of oligoclonal band negative multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Sequential changes in oligoclonal patterns during the course of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Natalizumab effects on immune cell responses in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

Bone-marrow transplantation fails to halt intrathecal lymphocyte activation in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970192-3

7 January 2021

10.1016/S1474-4422(08)70192-3

Identifiers

DOI

1 reference

4 August 2017

1 reference